191 related articles for article (PubMed ID: 16239349)
21. [Influence of HPV16 on expression of Rb, p16 and cyclin D1 in oral epithelial cell].
Sdek P; Zhang Z; Cao J
Zhonghua Kou Qiang Yi Xue Za Zhi; 2002 Mar; 37(2):84-6. PubMed ID: 12475413
[TBL] [Abstract][Full Text] [Related]
22. Synergistic effect of cyclin D1 and c-Myc leads to more aggressive and invasive mammary tumors in severe combined immunodeficient mice.
Wang Y; Thakur A; Sun Y; Wu J; Biliran H; Bollig A; Liao DJ
Cancer Res; 2007 Apr; 67(8):3698-707. PubMed ID: 17440082
[TBL] [Abstract][Full Text] [Related]
23. Molecular biology of laryngeal squamous cell carcinoma.
Nadal A; Cardesa A
Virchows Arch; 2003 Jan; 442(1):1-7. PubMed ID: 12536308
[TBL] [Abstract][Full Text] [Related]
24. Disease mechanism and biomarkers of oral squamous cell carcinoma.
Brinkman BM; Wong DT
Curr Opin Oncol; 2006 May; 18(3):228-33. PubMed ID: 16552233
[TBL] [Abstract][Full Text] [Related]
25. Spontaneous squamous cell carcinoma induced by the somatic inactivation of retinoblastoma and Trp53 tumor suppressors.
Martínez-Cruz AB; Santos M; Lara MF; Segrelles C; Ruiz S; Moral M; Lorz C; García-Escudero R; Paramio JM
Cancer Res; 2008 Feb; 68(3):683-92. PubMed ID: 18245467
[TBL] [Abstract][Full Text] [Related]
26. Clonal selection in malignant transformation of human fibroblasts transduced with defined cellular oncogenes.
Mahale AM; Khan ZA; Igarashi M; Nanjangud GJ; Qiao RF; Yao S; Lee SW; Aaronson SA
Cancer Res; 2008 Mar; 68(5):1417-26. PubMed ID: 18316605
[TBL] [Abstract][Full Text] [Related]
27. An in vitro multistep carcinogenesis model for human cervical cancer.
Narisawa-Saito M; Yoshimatsu Y; Ohno S; Yugawa T; Egawa N; Fujita M; Hirohashi S; Kiyono T
Cancer Res; 2008 Jul; 68(14):5699-705. PubMed ID: 18632622
[TBL] [Abstract][Full Text] [Related]
28. Diabetes and oral oncogenesis.
Vairaktaris E; Spyridonidou S; Goutzanis L; Vylliotis A; Lazaris A; Donta I; Perrea D; Yapijakis C; Patsouris E
Anticancer Res; 2007; 27(6B):4185-93. PubMed ID: 18225590
[TBL] [Abstract][Full Text] [Related]
29. Potential involvement of MYC- and p53-related pathways in tumorigenesis in human oral squamous cell carcinoma revealed by proteomic analysis.
Koehn J; Krapfenbauer K; Huber S; Stein E; Sutter W; Watzinger F; Erovic BM; Thurnher D; Schindler T; Fountoulakis M; Turhani D
J Proteome Res; 2008 Sep; 7(9):3818-29. PubMed ID: 18700792
[TBL] [Abstract][Full Text] [Related]
30. Stepwise neoplastic transformation of a telomerase immortalized fibroblast cell line.
Zongaro S; de Stanchina E; Colombo T; D'Incalci M; Giulotto E; Mondello C
Cancer Res; 2005 Dec; 65(24):11411-8. PubMed ID: 16357149
[TBL] [Abstract][Full Text] [Related]
31. Human calmodulin-like protein (CLP) expression in oral squamous mucosa and in malignant transformation.
Brooks MD; Bennett RD; Strehler EE; Sebo TJ; Eckert SE; Carr AB
J Prosthodont; 2009 Jan; 18(1):11-6. PubMed ID: 19166543
[TBL] [Abstract][Full Text] [Related]
32. K-Ras promotes growth transformation and invasion of immortalized human pancreatic cells by Raf and phosphatidylinositol 3-kinase signaling.
Campbell PM; Groehler AL; Lee KM; Ouellette MM; Khazak V; Der CJ
Cancer Res; 2007 Mar; 67(5):2098-106. PubMed ID: 17332339
[TBL] [Abstract][Full Text] [Related]
33. Identification of genes required for immortalization in human papillomavirus-infected human oral keratinocytes.
Nishitani J; Chen Z; Qin M; Liu F; Chen H; Nelson SF; Liu X
Cell Mol Biol (Noisy-le-grand); 2002; 48 Online Pub():OL331-41. PubMed ID: 12643451
[TBL] [Abstract][Full Text] [Related]
34. PI-3K/Akt signal pathway plays a crucial role in arsenite-induced cell proliferation of human keratinocytes through induction of cyclin D1.
Ouyang W; Li J; Zhang D; Jiang BH; Huang DC
J Cell Biochem; 2007 Jul; 101(4):969-78. PubMed ID: 17370311
[TBL] [Abstract][Full Text] [Related]
35. Oral cancer in the molecular age.
Regezi JA; Jordan RC
J Calif Dent Assoc; 2001 Aug; 29(8):578-84. PubMed ID: 11577668
[TBL] [Abstract][Full Text] [Related]
36. The co-expression of c-myc and p53 increases and reaches a plateau early in oral oncogenesis.
Papakosta V; Vairaktaris E; Vylliotis A; Derka S; Nkenke E; Vassiliou S; Lazaris A; Mourouzis C; Rallis G; Spyridonidou S; Anagnostopoulou S; Perrea D; Donta I; Yapijakis C; Patsouris E
Anticancer Res; 2006; 26(4B):2957-62. PubMed ID: 16886620
[TBL] [Abstract][Full Text] [Related]
37. Pyk2/ERK 1/2 mediate Sp1- and c-Myc-dependent induction of telomerase activity by epidermal growth factor.
Bermudez Y; Yang H; Cheng JQ; Kruk PA
Growth Factors; 2008 Feb; 26(1):1-11. PubMed ID: 18365874
[TBL] [Abstract][Full Text] [Related]
38. PTEN, more than the AKT pathway.
Blanco-Aparicio C; Renner O; Leal JF; Carnero A
Carcinogenesis; 2007 Jul; 28(7):1379-86. PubMed ID: 17341655
[TBL] [Abstract][Full Text] [Related]
39. Knock-in of mutant K-ras in nontumorigenic human epithelial cells as a new model for studying K-ras mediated transformation.
Konishi H; Karakas B; Abukhdeir AM; Lauring J; Gustin JP; Garay JP; Konishi Y; Gallmeier E; Bachman KE; Park BH
Cancer Res; 2007 Sep; 67(18):8460-7. PubMed ID: 17875684
[TBL] [Abstract][Full Text] [Related]
40. The SV40 large T antigen-p53 complexes bind and activate the insulin-like growth factor-I promoter stimulating cell growth.
Bocchetta M; Eliasz S; De Marco MA; Rudzinski J; Zhang L; Carbone M
Cancer Res; 2008 Feb; 68(4):1022-9. PubMed ID: 18281476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
